Weill Cornell Medicine researchers resolve how membrane lipid PIP2 locks CNG channels closed, revealing a therapeutic target for retinal degeneration.
Weill Cornell Medicine researchers resolve how membrane lipid PIP2 locks CNG channels closed, revealing a therapeutic target for retinal degeneration.